Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined treatment with cilostazol and aspirin in acute ischemic stroke
IRCT20241016063386N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cilostazol and aspirin in ischemic stroke, sponsored by Urmia University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
cilostazolaspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20241016063386N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241016063386N1.